Alto Neuroscience ANRO Shares Reserved for Future Issuance Under Stock Plans
Shares Reserved for Future Issuance Under Stock Plans at other companies
Other financials
Where this comes from
Reported directly by Alto Neuroscience in its filing.
Tagged under the XBRL concept us-gaap:CommonStockCapitalSharesReservedForFutureIssuance.
The official record: Alto Neuroscience’s 10-Q, filed May 13, 2026, on SEC EDGAR. View the filing →
Ask your AI about Alto Neuroscience's shares reserved for future issuance under stock plans.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is Alto Neuroscience's shares reserved for future issuance under stock plans?
- Alto Neuroscience (ANRO) reported shares reserved for future issuance under stock plans of 15.8M in Q1 2026.
- How has Alto Neuroscience's shares reserved for future issuance under stock plans changed year-over-year?
- Alto Neuroscience's shares reserved for future issuance under stock plans increased by 150.1% year-over-year, from 6.3M to 15.8M.
- What is the long-term trend for Alto Neuroscience's shares reserved for future issuance under stock plans?
- Over 2 years (2023 to 2025), Alto Neuroscience's shares reserved for future issuance under stock plans has grown at a -20.5% compound annual growth rate (CAGR), from 17.6M to 11.2M.
- What does shares reserved for future issuance under stock plans mean?
- This represents the total number of common shares authorized and set aside for future issuance to employees and directors under equity compensation plans. It provides insight into the potential future dilution of existing shareholders. Investors monitor this to assess the firm's long-term incentive structure.